Dr. Alexander Philipovskiy
Claim this profileFlorida Cancer Specialists
Studies Solid Tumors
Studies Lung Cancer
17 reported clinical trials
39 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
KRAS positive
2Lung Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Alexander Philipovskiy is currently running
Alintegimod + Ipilimumab + Nivolumab
for Cancer
This study is an open-label Phase Ib (Part A) dose escalation followed by a blinded, randomized, multi cohort Phase 2a (Part B) comparison of combination vs. reference regimens. Currently study will only be enrolling the Phase 1b and the Phase 2a protocol requirements will be added to the study near completion of the Phase 1b
Recruiting1 award Phase 1 & 2
LY4050784
for Advanced Cancer
The main purpose of this study is to find out whether the study drug, LY4050784, is safe, tolerable and effective in participants alone or in combination with other anticancer agents. In addition, with locally advanced or metastatic solid tumors with a BRG1 (Brahma-related gene 1, also known as SMARCA4) alteration who have previously received, do not qualify for, or are refusing standard of care treatments, or there is no standard therapy available for the disease. The study is conducted in two parts - phase Ia (dose-escalation) and phase Ib (dose-optimization, dose-expansion). The study will last up to approximately 4 years.
Recruiting1 award Phase 12 criteria
More about Alexander Philipovskiy
Clinical Trial Related3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Alexander Philipovskiy has experience with
- Atezolizumab
- Bevacizumab
- Docetaxel
- Nivolumab
- VIO-01
- PBI-200
Breakdown of trials Alexander Philipovskiy has run
Solid Tumors
Lung Cancer
Colorectal Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander Philipovskiy specialize in?
Alexander Philipovskiy focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Alexander Philipovskiy currently recruiting for clinical trials?
Yes, Alexander Philipovskiy is currently recruiting for 4 clinical trials in Lake Mary Florida. If you're interested in participating, you should apply.
Are there any treatments that Alexander Philipovskiy has studied deeply?
Yes, Alexander Philipovskiy has studied treatments such as Atezolizumab, Bevacizumab, Docetaxel.
What is the best way to schedule an appointment with Alexander Philipovskiy?
Apply for one of the trials that Alexander Philipovskiy is conducting.
What is the office address of Alexander Philipovskiy?
The office of Alexander Philipovskiy is located at: Florida Cancer Specialists, Lake Mary, Florida 32746 United States. This is the address for their practice at the Florida Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.